The idea of combining antihypertensive drugs, a statin, and sometimes aspirin into a polypill to prevent heart attacks and strokes is now a dozen years old, but still no drug is licensed in a high income country. This week researchers, funders, regulators, policymakers, and drug manufacturers gathered together in Hamilton, Canada, to review and perhaps […]
Richard Smith: Polypill summit hears of slow progress
